The purpose of the Scottsdale Research Institute, LLC, an Arizona-based Limited Liability Company is to coordinate rigorous, scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.
The SRI Institute will coordinate and support cannabis research throughout the State of Arizona and beyond. Research will focus on the potential medicinal benefits of cannabis for diseases and conditions as specified by the National Academy of Sciences, Institute of Medicine Report (1999) and by the Workshop on the Medical Utility of Marijuana, National Institutes of Health (1997).
The SRI will strive to conduct high quality, controlled scientific studies intended to ascertain the general medical safety and efficacy of cannabis and cannabis products and examine various forms of cannabis administration. The Institute will be seen as a model resource for health policy planning by virtue of its close collaboration with federal, state, and academic entities. The SRI will also highlight the current barriers to federally-regulated Marijuana Research.
The following diseases or conditions are additional areas of interest for future funding and research:
- Substitution therapy for opioid dependence, benzodiazepine withdrawal etc.
- Agitation in Alzheimer's disease
- Severe appetite suppression, weight loss, and cachexia due to HIV infection and other medical conditions
- Chronic pain, particularly neuropathic pain
- Severe nausea and vomiting associated with cancer and its treatment
- Severe muscle spasticity caused by diseases such as multiple sclerosis
- Autism, Autism Spectrum Disorders and other pervasive developmental disorders
The Institute will call for a 5-year program overseeing objective, high quality medical research that will “enhance understanding of the efficacy and adverse effects of marijuana as a pharmacological agent,” stressing that the project “should not be construed as encouraging or sanctioning the social or recreational use of marijuana”.
The Institute will also develop an awareness campaign addressing the persistent blockades to federally regulated whole plant marijuana research including continued partnership with MAPS to expose the failure of the DEA/NIDA monopoly.
Scottsdale Research Institute, LLC will be raising awareness about the barriers to conducting FDA-approved Marijuana Research, and strive to build relationships with elected officials & other community leaders who are open to discussing these hurdles.